CAMBRIDGE, Mass.--(BUSINESS WIRE)--Syros Pharmaceuticals today announced that it will present preclinical data on its first-in-class selective cyclin-dependent kinase 7 (CDK7) program in acute leukemias at the American Society of Hematology (ASH) Annual Meeting taking place December 5-8 in Orlando, Florida.
Help employers find you! Check out all the jobs and post your resume.
